Can you provide the average price target for CHEMOURS CO/THE stock?
18 analysts have analysed CC and the average price target is 20.02 USD. This implies a price decrease of -7.33% is expected in the next year compared to the current price of 21.6.
NYSE:CC • US1638511089
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CHEMOURS CO/THE (CC).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-05 | Mizuho | Maintains | Outperform -> Outperform |
| 2026-02-25 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2026-02-23 | BMO Capital | Maintains | Outperform -> Outperform |
| 2026-02-23 | UBS | Maintains | Buy -> Buy |
| 2026-02-23 | JP Morgan | Maintains | Neutral -> Neutral |
| 2026-02-23 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-21 | Truist Securities | Maintains | Buy -> Buy |
| 2025-12-03 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-11-11 | UBS | Maintains | Buy -> Buy |
| 2025-11-10 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-10 | Truist Securities | Maintains | Buy -> Buy |
| 2025-10-16 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-10-06 | UBS | Maintains | Buy -> Buy |
| 2025-09-23 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-09-16 | Truist Securities | Maintains | Buy -> Buy |
| 2025-07-15 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-07-03 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-05-28 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-14 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-05-12 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-05-07 | UBS | Maintains | Buy -> Buy |
| 2025-04-14 | Truist Securities | Maintains | Buy -> Buy |
| 2025-04-01 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-03-27 | Mizuho | Upgrade | Neutral -> Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.078B -10.54% | 5.782B -4.87% | 5.808B 0.45% | 6.154B 5.96% | 6.504B 5.69% | 6.758B 3.91% | |
| EBITDA YoY % growth | 215M -80.07% | 736M 242.33% | 335M -54.48% | 864.27M 157.99% | 1.004B 16.17% | 1.102B 9.76% | |
| EBIT YoY % growth | -92M -111.68% | 435M 572.83% | -5M -101.15% | 518.02M 10,460.40% | 658.41M 27.10% | 755.11M 14.69% | |
| Operating Margin | -1.51% | 7.52% | -0.09% | 8.42% | 10.12% | 11.17% | |
| EPS YoY % growth | 3.02 -34.20% | 1.21 -59.93% | 0.96 -20.66% | 1.43 48.81% | 2.28 59.39% | 2.79 22.66% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.05 -139.72% | 0.66 13.41% | 0.57 183.57% | 0.22 349.59% | 0.43 931.18% | 0.82 25.27% | 0.73 28.94% | 0.31 38.98% |
| Revenue Q2Q % growth | 1.425B 4.17% | 1.698B 5.14% | 1.596B 6.76% | 1.416B 6.47% | 1.552B 8.91% | 1.769B 4.18% | 1.71B 7.14% | 1.503B 6.14% |
| EBITDA Q2Q % growth | 141.84M -18.48% | 276.23M 4,046.14% | 260.08M -27.15% | 192.34M -43.26% | 230.45M 62.47% | 293.94M 6.41% | 271.99M 4.58% | 201.87M 4.95% |
| EBIT Q2Q % growth | 58.843M -31.58% | 191.02M 202.15% | 178.47M 82.11% | 114.76M 11,576.00% | 145.3M 146.93% | 227.06M 18.87% | 192.24M 7.72% | 113.07M -1.47% |
All data in USD
18 analysts have analysed CC and the average price target is 20.02 USD. This implies a price decrease of -7.33% is expected in the next year compared to the current price of 21.6.
CHEMOURS CO/THE (CC) will report earnings on 2026-05-04.
The consensus EPS estimate for the next earnings of CHEMOURS CO/THE (CC) is -0.05 USD and the consensus revenue estimate is 1.43B USD.
The expected long term growth rate for CHEMOURS CO/THE (CC) is 4.19%.